Literature DB >> 8806570

High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai.

C S Dunn1, C Beyer, M P Kieny, L Gloeckler, D Schmitt, J P Gut, A Kirn, A M Aubertin.   

Abstract

Chimeric primate lentiviruses composed of SIV and HIV genes may allow the analysis of the role of these discrete HIV genes in viral pathogenesis in macaque monkeys. We have constructed a chimeric virus in which the env, rev, tat, and vpu genes of HIV-1 Lai replace the env, rev, and tat genes of the SIVmac239 genome. This virus, SHIVsbg, replicates efficiently in rhesus (Indian and Chinese subspecies) and cynomolgus monkeys with viral loads in PBMC and lymph nodes of up to one infected cell per 30 cells during the acute phase of the infection. Sera from all monkeys recognize specific HIV-1 glycoproteins. The onset of lymphadenopathy in all animals was concurrent with a depletion of CD4 lymphocytes in peripheral blood. The virulence of this SHIV for rhesus and cynomolgus monkeys therefore closely parallels that of HIV-1 for human in the acute phase of the infection. Changes in the env and vpu genes of a molecular clone of HIV-1 can now be analyzed after passage in nonhuman primate species as the SHIVsbg replicates efficiently. The SHIVsbg-macaque model is an important step in the development of a readily available animal model for HIV-1 vaccine studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806570     DOI: 10.1006/viro.1996.0486

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.

Authors:  Keith A Reimann; Robert A Parker; Michael S Seaman; Kristin Beaudry; Margaret Beddall; Lauren Peterson; Kenneth C Williams; Ronald S Veazey; David C Montefiori; John R Mascola; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.

Authors:  Lisa A Chakrabarti; Tijana Ivanovic; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.

Authors:  G B Karlsson; M Halloran; J Li; I W Park; R Gomila; K A Reimann; M K Axthelm; S A Iliff; N L Letvin; J Sodroski
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.

Authors:  A Li; H Katinger; M R Posner; L Cavacini; S Zolla-Pazner; M K Gorny; J Sodroski; T C Chou; T W Baba; R M Ruprecht
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Sangita P Patil; Jan Kristoff; Marianne Bryan; Ronald C Montelaro; Alison Morris; Karen A Norris
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

6.  Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques.

Authors:  Chang Li; Zhenwei Shen; Xiao Li; Jieying Bai; Lin Zeng; Mingyao Tian; Ying Jin Song; Ming Ye; Shouwen Du; Dayong Ren; Cunxia Liu; Na Zhu; Dandan Sun; Yi Li; Ningyi Jin
Journal:  Clin Dev Immunol       Date:  2012-02-26

7.  Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.

Authors:  Mark Page; Richard Stebbings; Neil Berry; Robin Hull; Deborah Ferguson; Leanne Davis; Laura Duffy; William Elsley; Joanna Hall; Claire Ham; Mark Hassall; Bo Li; Edward T Mee; Ruby Quartey-Papafio; Nicola J Rose; Nathalie Mathy; Gerald Voss; E James Stott; Neil Almond
Journal:  Retrovirology       Date:  2012-07-16       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.